EGTX (EGTX) News
Track canonical SquawkNews coverage tagged to EGTX, EGTX. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Egetis Therapeutics to participate in September investor conferences
Egetis Therapeutics AB (publ) (NASDAQ Stockholm: EGTX) says it will participate in investor conferences in September, including the Cantor Global Healthcare Conference 2026 on Friday, September 11, 2026.
EQUITY | Sep 03, 2026, 06:10 AM UTC
L
Tiratricol granted orphan drug designation for MCT8 deficiency in Japan
Tiratricol has been granted orphan drug designation for MCT8 deficiency in Japan.
EQUITY | Aug 31, 2026, 06:00 AM UTC